[Des-Arg9]-Bradykinin is a Bradykinin (B1) receptor agonist that displays selectivity for B1 over B2 receptors.
CAT No: R1119
CAS No: 15958-92-6
Synonyms/Alias: [Des-Arg9]-BRADYKININ;15958-92-6;9-De-arg-bradykinin;Des-arg(9)-bradykinin;9-Des-arg-BK;(Des-Arg9)-Bradykinin;9-de-L-Argininebradykinin;1-8-Bradykinin;Bradykinin[1-8];58QE2VVE3Q;(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid;Bradykinin(1-8);MFCD00236892;Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe;Bradykinin, des-arg(9);[des-Arg(9)]-bradykinin;Bradykinin, des-arg(9)-;Bradykinin, des-arginine(9)-;RPPGFSPF;(Des-Arg9)-Bradykinin acetate salt;desArg9-BK;DABK;1-Des-arg-bradykinin;Des-arg(1) bradykinin;Bradykinin, des-arg(1)-;UNII-58QE2VVE3Q;DES-ARG9 BRADYKININ;l-arginyl-l-prolyl-l-prolylglycyl-l-phenylalanyl-l-seryl-l-prolyl-l-phenylalanine;Bradykinin, de-arginine(1)-;Bradykinin, 1-de-L-arginine-;CHEMBL1890370;CHEBI:133068;VCEHWDBVPZFHAG-POFDKVPJSA-N;HY-P0298;Bradykinin 1-8 acetate salt hydrate;AKOS024457375;NCGC00167250-01;DA-69137;G77854;L-Arg-L-Pro-L-Pro-Gly-L-Phe-L-Ser-L-Pro-L-Phe;(Des-Arg9)-Bradykinin acetate (H-L-Arg-L-Pro-L-Pro-Gly-L-Phe-L-Ser-L-Pro-L-Phe-OH);(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-(2-{[(2S)-1-[(2S)-1-[(2S)-2-AMINO-5-CARBAMIMIDAMIDOPENTANOYL]PYRROLIDINE-2-CARBONYL]PYRROLIDIN-2-YL]FORMAMIDO}ACETAMIDO)-3-PHENYLPROPANAMIDO]-3-HYDROXYPROPANOYL]PYRROLIDIN-2-YL]FORMAMIDO}-3-PHENYLPROPANOIC ACID;(S)-2-((S)-1-((S)-2-((S)-2-(2-((S)-1-((S)-1-((S)-2-amino-5-guanidinopentanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)-3-phenylpropanamido)-3-hydroxypropanoyl)pyrrolidine-2-carboxamido)-3-phenylpropanoic acid;ALANINE, N-(1-(N-(N-(N-(1-(1-L-ARGINYL-L-PROLYL)-L-PROLYL)GLYCYL)-3-PHENYL-L-ALANYL)-L-SERYL)-L-PROLYL)-3-PHENYL-;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C44H61N11O10 |
M.W/Mr. | 904 |
Sequence | One Letter Code:RPPGFSPF Three Letter Code:H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-OH |
InChI | InChI=1S/C44H61N11O10/c45-29(15-7-19-48-44(46)47)40(61)55-22-10-18-35(55)42(63)54-21-8-16-33(54)38(59)49-25-36(57)50-30(23-27-11-3-1-4-12-27)37(58)52-32(26-56)41(62)53-20-9-17-34(53)39(60)51-31(43(64)65)24-28-13-5-2-6-14-28/h1-6,11-14,29-35,56H,7-10,15-26,45H2,(H,49,59)(H,50,57)(H,51,60)(H,52,58)(H,64,65)(H4,46,47,48)/t29-,30-,31-,32-,33-,34-,35-/m0/s1 |
InChI Key | VCEHWDBVPZFHAG-POFDKVPJSA-N |
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.